From January 1, 2022 to January 21, 2022, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 2,060,000 shares, representing 2.14% for CNY 63.33 million under the buyback announced on January 23, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.23 CNY | -1.49% | -7.35% | -39.06% |
Jul. 02 | Tranche Update on Zhejiang AngLiKang Pharmaceutical CO.,LTD.'s Equity Buyback Plan announced on August 31, 2023. | CI |
Jul. 02 | Anglikang Pharmaceutical's Two Drugs Get Marketing Nod | MT |
1st Jan change | Capi. | |
---|---|---|
-39.06% | 364M | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- 002940 Stock
- News Zhejiang AngLiKang Pharmaceutical CO.,LTD.
- Tranche Update on Zhejiang AngLiKang Pharmaceutical CO.,LTD.'s Equity Buyback Plan announced on January 23, 2021.